FAM
MDGL icon

Fred Alger Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Fred Alger Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$544K Buy
+1,039
New +$496K ﹤0.01% 380
2024
Q4 		– Sell
-93,446
Closed -$19.8M – 449
2024
Q3 		$19.8M Sell
93,446
-9,009
-9% -$2.3M 0.1% 134
2024
Q2 		$28.7M Buy
102,455
+37,879
+59% +$9.02M 0.14% 102
2024
Q1 		$17.2M Buy
64,576
+46,479
+257% +$11M 0.09% 157
2023
Q4 		$4.19M Sell
18,097
-1,767
-9% -$309K 0.02% 265
2023
Q3 		$2.9M Buy
19,864
+456
+2% +$85.8K 0.02% 291
2023
Q2 		$4.48M Sell
19,408
-1,458
-7% -$395K 0.02% 259
2023
Q1 		$5.05M Buy
20,866
+4,746
+29% +$1.29M 0.03% 254
2022
Q4 		$4.68M Buy
+16,120
New +$1.58M 0.03% 267
2019
Q3 		– Sell
-11,000
Closed -$1.15M – 522
2019
Q2 		$1.15M Sell
11,000
-7,333
-40% -$785K ﹤0.01% 331
2019
Q1 		$2.3M Sell
18,333
-195
-1% -$24.2K 0.01% 276
2018
Q4 		$2.09M Buy
18,528
+5,782
+45% +$895K 0.01% 280
2018
Q3 		$2.73M Sell
12,746
-2,282
-15% -$573K 0.01% 265
2018
Q2 		$4.2M Buy
15,028
+6,028
+67% +$1.06M 0.02% 239
2018
Q1 		$1.05M Buy
9,000
+3,000
+50% +$370K ﹤0.01% 333
2017
Q4 		$551K Buy
+6,000
New +$343K ﹤0.01% 365

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fred Alger Management's MDGL Position: Q1 2026 in Review

Fred Alger Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2026: 1,039 shares worth $544K. The stake represents ﹤0.01% of the portfolio and ranks #380 among its holdings. This is a return to the name: Fred Alger Management previously reported a position in MDGL as recently as Q3 2024.

Fred Alger Management first reported a position in MDGL in Q4 2017 and has held it in 16 quarters since. The position peaked at $28.7M in Q2 2024. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Fred Alger Management held 1,039 shares of Madrigal Pharmaceuticals worth $544K as of Q1 2026.
  • Madrigal Pharmaceuticals was a new Fred Alger Management position in Q1 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Fred Alger Management's portfolio in Q1 2026, its #380 holding.
  • Fred Alger Management first reported a position in Madrigal Pharmaceuticals in Q4 2017 and has held it in 16 quarters since.
  • Fred Alger Management's Madrigal Pharmaceuticals position peaked at $28.7M in Q2 2024.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.